$6.28
00.00%
Last update: 7:03 AM
15 minutes delayed
Comments
Loading...
C4 Therapeutics (CCCC) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestC4 Therapeutics (NASDAQ:CCCC) Stock Quotes, Forecast and News Summary
C4 Therapeutics Stock (NASDAQ: CCCC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy C4 Therapeutics (CCCC) stock?
You can purchase shares of C4 Therapeutics (NASDAQ:CCCC) through any online brokerage.
Who are C4 Therapeutics (CCCC) competitors?
Other companies in C4 Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Inozyme Pharma (NASDAQ:INZY) and Larimar Therapeutics (NASDAQ:LRMR).
What is the forecast, or price target, for C4 Therapeutics (CCCC) stock?
C4 Therapeutics has a consensus price target of $16.18.
What is the current price for C4 Therapeutics (CCCC)?
The stock price for C4 Therapeutics (NASDAQ: CCCC) is $6.295 last updated September 25, 2024 at 12:54 PM EDT.
Does C4 Therapeutics (CCCC) pay a dividend?
There are no upcoming dividends for C4 Therapeutics.
When is C4 Therapeutics (NASDAQ:CCCC) reporting earnings?
C4 Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
Is C4 Therapeutics (CCCC) going to split?
There is no upcoming split for C4 Therapeutics.
What sector and industry does C4 Therapeutics (CCCC) operate in?
C4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.